-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GbALhf/V/uVlStKQjOx9UOHc3ii8+orDDfV3lN+989pwRRtuSn0DmLBhXiA0Xjbq
 c4JQJIdJ2u3hZq/6m9dPpg==

<SEC-DOCUMENT>0001309014-08-000335.txt : 20080605
<SEC-HEADER>0001309014-08-000335.hdr.sgml : 20080605
<ACCEPTANCE-DATETIME>20080605085832
ACCESSION NUMBER:		0001309014-08-000335
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20080605
FILED AS OF DATE:		20080605
DATE AS OF CHANGE:		20080605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KONINKLIJKE PHILIPS ELECTRONICS NV
		CENTRAL INDEX KEY:			0000313216
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05146-01
		FILM NUMBER:		08881997

	BUSINESS ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC
		BUSINESS PHONE:		31 20 59 77777

	MAIL ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS ELECTRONICS N V
		DATE OF NAME CHANGE:	19930727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS NV
		DATE OF NAME CHANGE:	19910903
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>htm_3115.htm
<DESCRIPTION>LIVE FILING
<TEXT>
<!-- HTML Header Page -->
<HTML>
<HEAD>
<TITLE>
Koninklijke Philips Electronics N.V.&nbsp;-&nbsp;Form&nbsp;6-K
</TITLE>
</HEAD>
<!-- End HTML Header Page --><!-- Cover Page Header -->
<BODY bgcolor=white text=black>
<HR NOSHADE>
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<P align="center">
<FONT size="+1"><B>
UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B>
</P>

<P>
<CENTER>
<FONT SIZE="+2" FACE="Arial"><B>Form 6-K</B></FONT><BR>

</CENTER>
</P>

<P>
<CENTER>
<FONT size="+1">
REPORT OF FOREIGN PRIVATE ISSUER<BR>PURSUANT TO RULE 13a-16 OR 15d-16<BR>UNDER THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</CENTER>
</P>
<P>
<CENTER>
June 5, 2008
</CENTER>
</P>
<P>
<CENTER>

</CENTER>
</P>
<!-- End Cover Page Header -->
<!-- Cover Page Registrant -->
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	<FONT SIZE="+2"><B>Koninklijke Philips Electronics N.V.</B></FONT><BR>
	<FONT SIZE="-7">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="CENTER" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	<FONT SIZE="-1">(Translation of registrant&#146;s name into English)</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	&nbsp;
    </TD>
  </TR>
<TR><TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5"><FONT FACE="Courier" SIZE="+0">The Netherlands</FONT><BR><FONT SIZE="-7">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;</FONT></TD></TR><TR><TD VALIGN="CENTER" ALIGN="CENTER" WIDTH="100%" COLSPAN="5"><FONT SIZE="-1">(Jurisdiction of incorporation or organization)</FONT></TD></TR><TR><TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">&nbsp;</TD></TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
      <FONT FACE="Courier" SIZE="+0">Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
        <FONT SIZE="-7">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;</FONT><BR>
	    <FONT SIZE="-1">(Address of principal executive office)</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	&nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Cover Page Registrant -->
<!-- Checkboxes Page -->
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%" COLSPAN="5">
	Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:&nbsp;&nbsp;[<FONT FACE="Courier">x</FONT>]&nbsp;Form 20-F&nbsp;&nbsp;&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]&nbsp;Form 40-F
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;[<FONT FACE="Courier">x</FONT>]&nbsp;No
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>
</TABLE>

<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
        If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):&nbsp;&nbsp;&nbsp;<FONT FACE="Courier"><U>&nbsp;n/a&nbsp;</U></FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Checkboxes Page -->
<!-- HR Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End HR Page Break --><!-- Report Page -->
<FONT SIZE="3">
<PRE>
This report comprises a copy the following press releases entitled:

- - &#8220;Philips announces completion of sale of Set-Top Boxes and Connectivity
Solutions businesses to Pace Micro Technology of the UK&#8221;, dated April 21, 2008;
- - &#8220;Philips plans to participate in TSMC share repurchase program&#8221;, dated May 13,
2008;
- - &#8220;Philips to acquire Brazilian patient monitoring and critical care company
DixtalBiom&#233;dica e Tecnologia&#8221;, dated May 13, 2008;
- - &#8220;Philips agrees to sell MedQuist stake to CBay Systems&#8221;, dated May 22, 2008;
- - &#8220;Philips completes cancellation of 36.6 million shares&#8221;, dated June 3, 2008.

</PRE>
</FONT>
<!-- End Report Page -->
<!-- Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
 <!-- Page Break  -->
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End Page Break -->
<!-- Signatures Page Header -->
<FONT SIZE="+1">
<CENTER>
<B>SIGNATURES</B>
</CENTER>
</FONT>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
       &nbsp;
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
       Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
       &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Signatures Page Header -->
<!-- Signatures Page Details -->
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       Koninklijke Philips Electronics N.V.
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="TOP" ALIGN="LEFT" WIDTH="40%">
       Date: June 5, 2008
    </TD>
    <TD VALIGN="TOP" ALIGN="LEFT" WIDTH="4%%">
       By:
    </TD>
    <TD VALIGN="TOP" ALIGN="LEFT" WIDTH="56%">
       /s/ E.P. Coutinho<BR><HR WIDTH="30%" NOSHADE>
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       Name:&nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
        E.P. Coutinho
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       Title:
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       General Secretary
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Signatures Page Details -->
<!-- HR Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End HR Page Break --><!-- Exhibit Index Header Page -->
<CENTER>
<FONT SIZE="+1"><B>
EXHIBIT&nbsp;INDEX
</B></FONT>
</CENTER>
<BR>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="60%">
  <TR VALIGN="BOTTOM">
    <TD NOWRAP ALIGN="LEFT" WIDTH="8%">
      <FONT SIZE="-1"><B>Exhibit No.</B></FONT>
    </TD>
    <TD WIDTH="15%">
      &nbsp;
    </TD>
    <TD NOWRAP ALIGN="LEFT" WIDTH="77%">
      <FONT SIZE="-1"><B>Description</B></FONT>
    </TD>
  </TR>
  <TR VALIGN="BOTTOM">
    <TD NOWRAP ALIGN="CENTER" WIDTH="8%">
      <HR SIZE="1" NOSHADE>
    </TD>
    <TD WIDTH="15%">
      &nbsp;
    </TD>
    <TD NOWRAP ALIGN="CENTER" WIDTH="77%">
      <HR ALIGN="LEFT" SIZE="1" WIDTH="88%" NOSHADE>
    </TD>
  </TR>
<!-- Exhibit Index Header Page -->
<!-- Exhibit Index Item -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      <FONT SIZE="-1">99.1<FONT>
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      <FONT SIZE="2">Press release</FONT>
    </TD>
  </TR>
<!-- End Exhibit Index Item -->
<!-- Exhibit Index Item -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      <FONT SIZE="-1">99.2<FONT>
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      <FONT SIZE="2">Press release</FONT>
    </TD>
  </TR>
<!-- End Exhibit Index Item -->
<!-- Exhibit Index Item -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      <FONT SIZE="-1">99.3<FONT>
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      <FONT SIZE="2">Press release</FONT>
    </TD>
  </TR>
<!-- End Exhibit Index Item -->
<!-- Exhibit Index Item -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      <FONT SIZE="-1">99.4<FONT>
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      <FONT SIZE="2">Press release</FONT>
    </TD>
  </TR>
<!-- End Exhibit Index Item -->
<!-- Exhibit Index Item -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      <FONT SIZE="-1">99.5<FONT>
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      <FONT SIZE="2">Press release</FONT>
    </TD>
  </TR>
<!-- End Exhibit Index Item -->
<!-- ExhibitIndexFooter -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      &nbsp;
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End ExhibitIndexFooter -->
<!-- HR Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End HR Page Break --><!-- HTML Footer Page -->
</BODY>
</HTML>
<!-- End HTML Footer Page -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- ExhibitContentHeader Page -->
<HTML>
<HEAD>
<TITLE>
Exhibit&nbsp;&nbsp;EX-99.1
</TITLE>
</HEAD>
<!-- End HTML Header Page -->
<!-- ExhibitContentPage -->

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt">Philips announces completion of sale of Set-Top Boxes and Connectivity Solutions businesses to
Pace Micro Technology of the UK
</FONT>

<P align="left" style="font-size: 12pt">Monday, April&nbsp;21, 2008


<P align="left" style="font-size: 12pt">Amsterdam, The Netherlands <B>&#150; </B>Royal Philips Electronics (AEX: PHI, NYSE: PHG) today announced it has
completed the sale of its Set-Top Boxes (STB)&nbsp;and Connectivity Solutions (CS)&nbsp;businesses, which
were part of its Home Networks business unit within its Consumer Lifestyle sector, to U.K.-based
technology provider Pace Micro Technology (FTSE: PIC).
<BR>
Philips received 64.5&nbsp;million Pace shares, representing a 21.6% shareholding, with an approximate
current market value of EUR 75&nbsp;million. In addition, Philips will receive a total cash payment of
EUR 5&nbsp;million in the coming three years. The transaction will result in a gain of approximately EUR
55&nbsp;million to be booked in the results of Philips&#146; Consumer Lifestyle sector in the second quarter
of 2008.
<BR>
Generating revenues of EUR 416&nbsp;million in 2007, the STB and CS businesses together employ
approximately 320 people, predominantly in France, who will transfer to Pace as part of the
transaction. The transaction combines the strengths of two leading players in the industry,
creating one of the largest set-top-box players in the world at a time when the shift from analog
to digital TV is rapidly increasing.


<P align="left" style="font-size: 12pt">For further information, please contact:
<BR>
Jayson Otke
<BR>
Philips Corporate Communications
<BR>
Tel: &nbsp;&#043;31 20 5977215&nbsp;&nbsp;&nbsp;
<BR>
Email: &nbsp;jayson.otke@philips.com


<P align="left" style="font-size: 12pt">About Royal Philips Electronics
<BR>
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in
healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products,
services and solutions through the brand promise of &#147;sense and simplicity&#148;. Headquartered in the
Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27&nbsp;billion in 2007, the company is a market leader in medical diagnostic imaging
and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions
for personal wellbeing. News from Philips is located at www.philips.com/newscenter<I>.</I>

&nbsp;

<P align="left" style="font-size: 12pt">About Pace Micro Technology
<BR>
Pace Micro Technology plc (pic.l) is a leading technology developer for the global payTV industry.
Pace&#146;s main focus is on creating intelligent and innovative products and services that benefit our
customers and fuel the development of digital TV. Over the last 25&nbsp;years, Pace has developed one of
the world&#146;s most experienced specialist engineering teams and is now the partner of choice for
leading payTV operators across the globe. Pace&#146;s international headquarters are in Saltaire, West
Yorkshire, UK, with further offices in the USA, France, India and Hong Kong. For more information
on Pace, please visit www.pacemicro.com.


<P align="left" style="font-size: 12pt">Forward-looking statements
<BR>
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements. Any forward-looking statements
in this announcement are based upon information known to Philips on the date of this announcement.
Philips undertakes no obligation to publicly update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise



<P align="center" style="font-size: 10pt; display: none">


<!-- v.060107 -->
</BODY>

<!-- End ExhibitContentPage -->
<!-- ExhibitContentFooter Page -->
</HTML>
<!-- ExhibitContentFooter Page -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<!-- ExhibitContentHeader Page -->
<HTML>
<HEAD>
<TITLE>
Exhibit&nbsp;&nbsp;EX-99.2
</TITLE>
</HEAD>
<!-- End HTML Header Page -->
<!-- ExhibitContentPage -->

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt">Philips plans to participate in TSMC share repurchase program
</FONT>

<P align="left" style="font-size: 12pt">Tuesday, May&nbsp;13, 2008


<P align="left" style="font-size: 12pt">Amsterdam, The Netherlands &#150; Royal Philips Electronics (NYSE:PHG, AEX:PHI) today announced that,
market conditions permitting, it plans to sell common shares in Taiwan Semiconductor Manufacturing
Company Ltd. (TAIEX: 2330, NYSE: TSM) in a share repurchase program as announced by TSMC.


<P align="left" style="font-size: 12pt">This TSMC share repurchase program is part of the fourth step in the multi-phased plan to
facilitate an orderly exit by Philips from its shareholding in TSMC as announced by Philips and
TSMC on March&nbsp;9, 2007. This plan aims to reduce Philips&#146; holding in TSMC to zero before the end of
2010. Today, TSMC has announced it plans to execute this share buyback program via open market
transactions on the Taiwan Stock Exchange for up to USD 1&nbsp;billion worth of shares. Philips plans to
participate in additional share repurchase programs in the next years as part of its effort to
further build down its holding in TSMC.


<P align="left" style="font-size: 12pt">Currently, Philips holds approximately 1.3&nbsp;billion TSMC shares representing approximately 5% of
TSMC&#146;s issued shares. This total stake is worth approximately USD 2.8&nbsp;billion at current market
prices of TSMC shares.


<P align="left" style="font-size: 12pt">For more information, please contact:
<BR>
Arent Jan Hesselink
<BR>
Philips Corporate Communications
<BR>
Tel: &nbsp;&#043;31 20 59 77415&nbsp;&nbsp;&nbsp;
<BR>
Email: &nbsp;arentjan.hesselink@philips.com


<P align="left" style="font-size: 12pt">About Royal Philips Electronics
<BR>
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in
healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products,
services and solutions through the brand promise of &#147;sense and simplicity&#148;. Headquartered in the
Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27&nbsp;billion in 2007, the company is a market leader in medical diagnostic imaging
and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions
for personal wellbeing. News from Philips is located at www.philips.com/newscenter.


<P align="left" style="font-size: 12pt">Forward-looking statements
<BR>
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements. In particular, the offer and
sale by Philips of TSMC shares, and the proceeds of any such sales, will depend on equity capital
market conditions, particularly those affecting the semiconductor industry.


<P align="left" style="font-size: 12pt">&nbsp;This release does not constitute an offer of any securities for sale. Any offer or sale of
securities shall be made by means of a registration statement filed with the U.S. Securities and
Exchange Commission under the Securities Act of 1933 or by means of an exemption from the
registration requirements thereof.



<P align="center" style="font-size: 10pt; display: none">


<!-- v.060107 -->
</BODY>

<!-- End ExhibitContentPage -->
<!-- ExhibitContentFooter Page -->
</HTML>
<!-- ExhibitContentFooter Page -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit3.htm
<DESCRIPTION>EX-99.3
<TEXT>
<!-- ExhibitContentHeader Page -->
<HTML>
<HEAD>
<TITLE>
Exhibit&nbsp;&nbsp;EX-99.3
</TITLE>
</HEAD>
<!-- End HTML Header Page -->
<!-- ExhibitContentPage -->

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt">Philips to acquire Brazilian patient monitoring and critical care company Dixtal Biom&#233;dica e
Tecnologia
</FONT>

<P align="left" style="font-size: 12pt">Tuesday, May&nbsp;13, 2008


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&#149;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Move further bolsters Philips&#146; healthcare presence in high-growth emerging markets</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">&#149;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Dixtal&#146;s economy- to mid-range patient monitoring, anesthesia and ventilation products
to broaden Philips&#146; presence in key &#145;critical care&#146; market</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt">Amsterdam, the Netherlands and S&#227;o Paulo, Brazil <B>&#150; </B>Royal Philips Electronics (NYSE: PHG, AEX: PHI)
today announced it has reached an agreement to acquire Brazilian-based Dixtal Biom&#233;dica e
Tecnologia (&#147;Dixtal&#148;). Dixtal is a leading Brazilian manufacturer of in-hospital patient
monitoring, anesthesia, ventilation equipment, and ECG (electrocardiogram)&nbsp;as well as other sensors
for vital sign measurements. Dixtal will become part of the Patient Monitoring business within
Philips&#146; Healthcare sector, and Philips expects Dixtal&#146;s financial results will be consolidated in
this business as of the third quarter of 2008. The terms of the deal were not disclosed.


<P align="left" style="font-size: 12pt">Today&#146;s announcement marks another step Philips is taking to expand its presence in high-growth
healthcare markets in emerging economies, following the company&#146;s earlier announced acquisitions of
healthcare companies Shenzhen Goldway Industrial in China and VMI Sistemas Medicos in Brazil. In
commenting on the deal, Mr.&nbsp;Daurio Speranzini J&#250;nior, Senior Vice-President of Philips Healthcare
Latin America, said: &#147;Emerging markets represent a real opportunity for us to keep growing our
healthcare business at Philips. If you just take Latin America, our addressable healthcare market
in 2007 was estimated to be valued at approximately EUR 1.2&nbsp;billion, and growing at twice the rate
of developed markets. Acquiring Dixtal will help us further tap into that growth.&#148;


<P align="left" style="font-size: 12pt">Today&#146;s agreement with Dixtal will also bolster Philips&#146; presence in the global medical equipment
market for &#145;critical care&#146; &#150; that is, the medical equipment used to care for patients experiencing
acute and critical illness or injury. Mr.&nbsp;Speranzini J&#250;nior explains: &#147;In the hospital, a key
component of critical care is patient monitoring, and Philips already enjoys a leading global
position in this market. Acquiring Dixtal will not only extend Philips&#146; product portfolio to
include Dixtal&#146;s mid- to economy-range patient monitoring products, but through this move we&#146;ll
gain access to other key components of critical care &#150; Dixtal&#146;s anesthesia machines and its
invasive ventilation products. So this acquisition complements Philips&#146; recent move into the
non-invasive ventilation business through our acquisition earlier this year of US-based
Respironics. And since Dixtal and Philips use the same distribution channels vis-&#224;-vis hospitals
for all of our critical care businesses, we can expect significant synergies coming out of this
collaboration.&#148;


<P align="left" style="font-size: 12pt">Founded in 1978, Dixtal is a privately-held healthcare company headquartered in S&#227;o Paulo, Brazil.
Dixtal employs approximately 300 people, mainly in Brazil, of which 60 work in research &#038;
development. &#147;At Dixtal, we&#146;re committed to innovation, aesthetics, and product evolution, and our
passion to serve people has helped us become a leading medical equipment company in Brazil. Since
being founded 30&nbsp;years ago, we&#146;ve focused on helping hospitals provide the optimum in critical
care. We believe that combining our culture and capabilities with those of a world class company
like Philips will help us serve society better and expand our presence in Latin America and
beyond,&#148; said Albert Holzhacker, President of Dixtal.


<P align="left" style="font-size: 12pt">Over the last four years, Dixtal has tripled its revenues. Following completion of the acquisition,
growth is expected to accelerate further as Philips leverages Dixtal&#146;s strong contacts to local
hospitals and distributors, while Dixtal capitalizes on Philips&#146; global presence for its products.
Philips has an extensive presence in critical care through its leading position in the global
patient monitoring market, which in 2007 was estimated to be approximately USD 3&nbsp;billion or
approximately EUR 2&nbsp;billion.


<P align="left" style="font-size: 12pt">For further information, please contact:


<P align="left" style="font-size: 12pt">Jayson Otke
<BR>
Philips Corporate Communications
<BR>
Tel: &#043;31 20 5977215
<BR>
Email: <U>jayson.otke@philips.com</U>


<P align="left" style="font-size: 12pt">Andre Manning
<BR>
Philips Healthcare
<BR>
Tel: &#043;1 646 508 454
<BR>
Email: <U>andre.manning@philips.com</U>


<P align="left" style="font-size: 12pt">F&#225;bio Lopes
<BR>
Philips Brazil Corporate Comunications
<BR>
Tel: &#043;55 11 2125 0463
<BR>
Email: <U>fabio.lopes@philips.com </U>


<P align="left" style="font-size: 12pt">About Royal Philips Electronics
<BR>
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in
healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products,
services and solutions through the brand promise of &#147;sense and simplicity&#148;. Headquartered in the
Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27&nbsp;billion in 2007, the company is a market leader in medical diagnostic imaging
and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions
for personal wellbeing. News from Philips is located at <U>www.philips.com/newscenter</U>.


<P align="left" style="font-size: 12pt">About Dixtal Biom&#233;dica e Tecnologia
<BR>
Dixtal Biom&#233;dica e Tecnologia is a leading Brazilian patient monitoring and critical care equipment
manufacturer, with headquarters in S&#227;o Paulo. Founded in 1978 to develop and implement effective
solutions for the healthcare segment, the company today employs approximately 300 people, 60 of
them dedicated to research and development. Its complete portfolio includes physiological
multiparametric monitors, electrocardiographs, oximeters, capnographs, a clinical management
system, among other products.


<P align="left" style="font-size: 12pt">Forward-looking statements
<BR>
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements.



<P align="center" style="font-size: 10pt; display: none">


<!-- v.060107 -->
</BODY>

<!-- End ExhibitContentPage -->
<!-- ExhibitContentFooter Page -->
</HTML>
<!-- ExhibitContentFooter Page -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>5
<FILENAME>exhibit4.htm
<DESCRIPTION>EX-99.4
<TEXT>
<!-- ExhibitContentHeader Page -->
<HTML>
<HEAD>
<TITLE>
Exhibit&nbsp;&nbsp;EX-99.4
</TITLE>
</HEAD>
<!-- End HTML Header Page -->
<!-- ExhibitContentPage -->

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt">Philips agrees to sell MedQuist stake to CBay Systems
</FONT>

<P align="left" style="font-size: 12pt">Thursday, May&nbsp;22, 2008


<P align="left" style="font-size: 12pt">Amsterdam, the Netherlands and London, the United <B>Kingdom </B>&#150; Royal Philips Electronics (AEX: PHI,
NYSE: PHG) (&#147;Philips&#148;) today announced it has reached an agreement to sell its approximate 69.5%
ownership interest in MedQuist Inc. (Pink Sheets: MEDQ.PK) to CBay Systems Holdings (AIM: CBAY)
(&#147;CBay&#148;) for USD 11.00 per share, or approximately USD 285&nbsp;million (approximately EUR 185&nbsp;million).
The USD 11.00 per share purchase price represents a premium of 47% over the most recent trading
price of MedQuist&#146;s stock. The acquisition of the approximate 69.5% shareholding in MedQuist will
complement CBay Systems Holdings&#146; existing portfolio of businesses in medical transcription,
healthcare technology, and healthcare financial services, including CBay Systems &#038; Services Inc,
CBay Systems Private Ltd. and Mirrus Systems.


<P align="left" style="font-size: 12pt">The sale of Philips&#146; stake in MedQuist is expected to close during the third quarter of 2008, and
is conditional upon applicable regulatory approvals, approval by CBay shareholders at a general
meeting of shareholders, and the fulfillment of specific closing conditions. In connection with
this transaction, Philips will receive cash and a promissory note equivalent to approximately USD
7.50 per share, amounting to approximately USD 195&nbsp;million (approximately EUR 125&nbsp;million). The
remaining per share consideration of approximately USD 3.50 per share will be paid to Philips in
the form of a 7-year bond convertible into common stock of CBay. The financial results related to
this transaction, which are expected to be immaterial, will be booked under &#147;Discontinued
Operations&#148; in Philips&#146; third quarter 2008 results.


<P align="left" style="font-size: 12pt">Today&#146;s announcement follows a November&nbsp;2, 2007 announcement, in which Philips indicated its
intention to proceed with the sale of its approximate 69.5% ownership interest, as well as a July
6, 2007 announcement, in which Philips indicated it viewed its stake in MedQuist as a non-core
holding.


<P align="left" style="font-size: 12pt">For more information, please contact:


<P align="left" style="font-size: 12pt">Jayson Otke
<BR>
Philips Corporate Communications
<BR>
Tel: &#043;31 20 5977215
<BR>
Email: <U>jayson.otke@philips.com</U>


<P align="left" style="font-size: 12pt">David Wolf
<BR>
Philips Corporate Communications North America
<BR>
Tel: &#043;1 917 455 7857
<BR>
Email: <U>david.l.wolf@philips.com</U>


<P align="left" style="font-size: 12pt">Mark Court
<BR>
For CBay Systems Holdings Ltd.
<BR>
Buchanan Communications
<BR>
Tel: &#043; 44 (0)&nbsp;20 7466 500
<BR>
Email: <U>markc@buchanan.uk.com</U>


<P align="left" style="font-size: 12pt">About Royal Philips Electronics
<BR>
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in
healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products,
services and solutions through the brand promise of &#147;sense and simplicity&#148;. Headquartered in the
Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27&nbsp;billion in 2007, the company is a market leader in medical diagnostic imaging
and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions
for personal wellbeing. News from Philips is located at <U>www.philips.com/newscenter</U>.


<P align="left" style="font-size: 12pt">About CBay Systems Holdings Ltd.
<BR>
CBay Systems Holdings Ltd. is the holding company for a portfolio of businesses, including CBay
Systems &#038; Services Inc, CBay Systems Private Ltd, and Mirrus Systems, that provide medical
transcription, healthcare technology, and healthcare financial services to the US healthcare
industry. CBay Systems Holdings Ltd trades under the CBAY symbol on the AIM market of the London
Stock Exchange.


<P align="left" style="font-size: 12pt">Forward looking statements
<BR>
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements. Any forward-looking statements
in this announcement are based upon information known to Philips on the date of this announcement.
Philips undertakes no obligation to publicly update or revise any forward-looking statement,
whether as a result of new information, future events or otherwise.



<P align="center" style="font-size: 10pt; display: none">


<!-- v.060107 -->
</BODY>

<!-- End ExhibitContentPage -->
<!-- ExhibitContentFooter Page -->
</HTML>
<!-- ExhibitContentFooter Page -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>6
<FILENAME>exhibit5.htm
<DESCRIPTION>EX-99.5
<TEXT>
<!-- ExhibitContentHeader Page -->
<HTML>
<HEAD>
<TITLE>
Exhibit&nbsp;&nbsp;EX-99.5
</TITLE>
</HEAD>
<!-- End HTML Header Page -->
<!-- ExhibitContentPage -->

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt">Philips completes cancellation of 36.6&nbsp;million shares
</FONT>

<P align="left" style="font-size: 12pt">Tuesday, June&nbsp;03, 2008


<P align="left" style="font-size: 12pt">Amsterdam, The Netherlands <B>&#150; </B>Royal Philips Electronics (NYSE:PHG, AEX:PHI) announced today that it
has completed the cancellation of in total 36,653,831 shares which have been acquired for
cancellation purposes during the period starting March&nbsp;14, 2008 up to and including May&nbsp;28, 2008
against an average repurchase price of EUR 24.34 per share. These shares have been repurchased
under the EUR 5&nbsp;billion share repurchase program Philips announced on December&nbsp;19, 2007 which is
currently being executed.


<P align="left" style="font-size: 12pt">In connection with this share capital reduction, Philips has notified the Netherlands Authority for
the Financial Markets (AFM)&nbsp;that it no longer holds 5 per cent of its own shares. As a result of
this cancellation, Philips&#146; issued share capital as per today amounts to 1,046,265,843 shares.


<P align="left" style="font-size: 12pt">For further information, please contact:


<P align="left" style="font-size: 12pt">Arent Jan Hesselink
<BR>
Philips Corporate Communications
<BR>
Tel: &#043;31 20 59 77415
<BR>
Email: <U>arentjan.hesselink@philips.com</U>


<P align="left" style="font-size: 12pt">About Royal Philips Electronics
<BR>
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in
healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products,
services and solutions through the brand promise of &#147;sense and simplicity&#148;. Headquartered in the
Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27&nbsp;billion in 2007, the company is a market leader in medical diagnostic imaging
and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions
for personal wellbeing. News from Philips is located at www.philips.com/newscenter.


<P align="left" style="font-size: 12pt">Forward-looking statements
<BR>
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements.



<P align="center" style="font-size: 10pt; display: none">


<!-- v.060107 -->
</BODY>

<!-- End ExhibitContentPage -->
<!-- ExhibitContentFooter Page -->
</HTML>
<!-- ExhibitContentFooter Page -->
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
